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Living organisms are constantly exposed to space radiation that consists of energetic protons and 
other heavier charged particles. Whether spaceflight factors, microgravity in particular, affects on the 
cellular response to DNA damage induced by exposures to radiation or other toxic chemicals will have an 
impact on the radiation risks for the astronauts, as well as on the mutation rate in microorganisms, is still 
an open question. Although the possible synergistic effects of space radiation and other spaceflight 
factors have been investigated since the early days of the human space program, the published 
results were mostly conflicting and inconsistent. To investigate the effects of spaceflight on the 
cellular response to DNA damages, human fibroblast cells flown to the International Space 
Station (ISS) were treated with bleomycin for three hours in the true microgravity environment, 
which induces DNA damages including the double strand breaks (DSB) similar to the ionizing 
radiation. Damage in the DNA was measured by the phosphorylation of a histone protein H2AX 
(-H2AX), which showed slightly more foci in the cells on ISS than in the ground control. The 
expression of genes involved in the DNA damage response was also analyzed using the PCR 
array. Although a number of the genes, including CDKN1A and PCNA, were significantly 
altered in the cells after bleomycin treatment, no significant difference in the expression profile 
of DNA damage response genes was found between the flight and ground samples. At the time 
of the bleomycin treatment, the cells on the ISS were found to be proliferating faster than the 
ground control as measured by the percentage of cells containing positive Ti-67 signals. Our 
results suggested that the difference in -H2AX between flight and ground was due to the faster 
growth rate of the cells in space, but spaceflight did not affect the response of the DNA damage 
response genes to bleomycin treatment.  
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